UNITEDHEALTH GROUP INC (UNH)

Insider Trading Filed: 2026-04-06

Timothy P. Flynn, a director at UnitedHealth Group, acquired 350 shares of common stock on April 1, 2026, increasing his direct ownership to 10,589 shares.
In addition to his direct holdings, Flynn also owns 6,033 shares indirectly through a trust.
The acquisition of additional shares suggests Flynn's confidence in UnitedHealth Group's future and alignment with shareholder interests.

Insider Trading Filed: 2026-04-06

Valerie C. Montgomery Rice, a director of UnitedHealth Group, acquired 343 shares of the company's common stock on April 1, 2026, indicating her continued confidence in the company's future prospects.
The acquisition of shares by a director suggests positive insider sentiment and aligns with the company's long-term growth strategy.
As a director, Valerie C. Montgomery Rice's ownership of 7,615 shares demonstrates her alignment with shareholders and commitment to the company's success.

Insider Trading Filed: 2026-04-06

The reporting person, Scott M. Gottlieb, a director of UnitedHealth Group, has acquired 320 shares of the company's common stock through deferred stock units as part of his regular compensation.
The acquired shares are immediately vested but must be retained by the director until his completion of service on the Board.
This transaction indicates ongoing director-level commitment and alignment of interests between the reporting person and the company's shareholders.

Insider Trading Filed: 2026-04-06

Paul R. Garcia, a director of UnitedHealth Group, acquired 343 shares of the company's common stock through deferred stock units and direct stock grants on April 1, 2026.
Garcia's total direct beneficial ownership increased to 3,673 shares, while he also has indirect beneficial ownership of an additional 2,246 shares held through various trusts.
The insider buying activity by a director suggests they have a positive outlook on the company's future performance.

Insider Trading Filed: 2026-04-06

John H. Noseworthy, a director of UnitedHealth Group, acquired 320 shares of the company's common stock on April 1, 2026 through deferred stock units granted as part of his regular compensation.
This transaction increases Noseworthy's direct beneficial ownership in UnitedHealth Group to 7,369 shares.
The acquisition of shares by a director is generally viewed as a positive sign, as it aligns their interests with those of shareholders.

Insider Trading Filed: 2026-04-06

Kristen Gil, a director at UnitedHealth Group, acquired 320 shares of the company's common stock on April 1, 2026 through deferred stock units granted as director compensation.
Gil also holds an additional 3,800 shares of UnitedHealth Group's common stock indirectly through a trust.
The insider buying activity suggests that Gil has confidence in the company's prospects and is aligning her interests with those of shareholders.

Insider Trading Filed: 2026-04-06

Charles D. Baker, a director of UnitedHealth Group, acquired 343 shares of the company's common stock on April 1, 2026 through deferred stock units granted as part of his regular compensation.
The acquisition of these shares increases Baker's direct beneficial ownership in UnitedHealth Group to 2,163 shares.
The transaction appears to be a routine compensation-related equity award and does not indicate any significant change in Baker's ownership or investment strategy.

Insider Trading Filed: 2026-04-06

Frederick William McNabb III, a director of UnitedHealth Group, acquired 388 shares of the company's common stock on April 1, 2026, increasing his direct beneficial ownership to 15,162 shares.
The transaction involved deferred stock units granted as regular quarterly compensation for McNabb's service as a director, which are immediately vested but must be retained until the completion of his board service.
Insider transactions like this can provide insight into management's confidence in the company's future prospects and their alignment with shareholder interests.

Insider Trading Filed: 2026-04-06

The reporting person, Michele J. Hooper, a director of UnitedHealth Group Inc., acquired 206 shares of common stock through deferred stock units as part of her regular quarterly compensation.
The deferred stock units are immediately vested but must be retained by the director until the completion of her service on the Board.
The insider transaction represents a modest increase in the director's direct beneficial ownership of UnitedHealth Group shares, which now stands at 41,792 shares.

Current Report Filed: 2026-01-27

UnitedHealth Group reported strong Q4 2025 and full year 2025 financial results, indicating continued growth and profitability for the healthcare company.
The earnings release highlights the company's ability to navigate the evolving healthcare landscape and deliver value to its customers and shareholders.
The filing does not indicate any major leadership changes or material agreements that would significantly impact the company's operations or future prospects.

Important Information